VR Logo

Unrated

DSP Healthcare Fund - Regular Plan


Equity: Sectoral-Pharma

1 Lakh

Investment Grown to
₹ 1.40 Lakh

₹ 10000

Monthly SIP Grown to
₹ 1.48 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends paid by the mutual fund scheme are taxed at the rate of 10% (effectively 11.648%, including surcharge and cess). This is known as Dividend Distribution Tax (DDT). Though the investor does not pay this tax directly, it is deducted from the dividend income before passing on to the investor.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund 26.36 0.59 0.15 4.38 27.93 25.13 39.54 -- -- -- --
S&P BSE Healthcare TRI 22.22 0.36 -0.86 3.23 31.90 20.84 27.74 -- -- -- --
Equity: Sectoral-Pharma 23.80 0.45 -0.82 1.87 27.45 22.58 34.41 -- -- -- --
Rank within category 3 2 1 2 5 3 2 -- -- -- --
Number of funds in category 9 9 9 9 9 9 8 4 3 3 3

As on 03-Jul-2020

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
DSP Healthcare Fund - Regular Plan  | Invest Online
Unrated
Nov-18 39.54 -- -- 2.53 412
Nippon India Pharma Fund
Unrated
Jun-04 34.05 13.77 7.10 2.24 2,992
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund  | Invest Now
Unrated
Jul-18 35.81 -- -- 2.24 1,460
SBI Healthcare Opportunities Fund  | Invest Online
Unrated
Jul-99 32.95 4.82 0.54 2.33 1,139
Mirae Asset Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jul-18 40.40 -- -- 2.51 581

Best & Worst Performance

Best (Period) Worst (Period)
Week 15.03 (01-Apr-2020 - 09-Apr-2020) -12.84 (11-Mar-2020 - 18-Mar-2020)
Month 28.49 (23-Mar-2020 - 22-Apr-2020) -21.90 (20-Feb-2020 - 23-Mar-2020)
Quarter 42.17 (23-Mar-2020 - 22-Jun-2020) -9.28 (23-Dec-2019 - 23-Mar-2020)
Year 44.20 (24-Jun-2019 - 23-Jun-2020) -5.69 (22-Mar-2019 - 23-Mar-2020)

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund -- -- -- -- -- --
S&P BSE Healthcare TRI* 7.72 22.96 0.11 0.24 -- --
Equity: Sectoral-Pharma* 10.16 20.10 0.24 0.51 0.85 2.81
Rank within category -- -- -- -- -- --
Number of funds in category -- -- -- -- -- --

The Risk Measures have been calculated using calendar month returns for the last three years.

As on

* As on 30-Jun-2020

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 22
Top 10 Stocks (%) 59.09
Top 5 Stocks (%) 39.92
Top 3 Sectors (%) 94.24
Portfolio P/B Ratio 3.28
Portfolio P/E Ratio 26.71

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 17,297 29,284
Giant (%) 6.81 11.15
Large (%) 32.11 50.23
Mid (%) 26.54 23.97
Small (%) 34.54 14.65
Tiny (%) -- --

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
up Dr. Reddy's Lab Healthcare 32.17 10.41 5.33 9.48
equal JB Chemicals & Pharma Healthcare 20.40 9.22 4.01 9.22
up Ipca Laboratories Healthcare 34.65 11.48 6.13 9.02
up Divi's Laboratories Healthcare 42.24 8.41 3.98 7.84
up Torrent Pharmaceuticals Healthcare 39.53 4.36 2.46 4.36
up Indoco Remedies Healthcare 78.64 5.43 3.82 4.24
equal Sun Pharmaceutical Inds. Healthcare 30.39 14.33 3.96 3.96
equal Alembic Pharmaceuticals Healthcare 20.40 3.90 2.76 3.90
up Aarti Drugs Healthcare 20.99 3.77 2.13 3.77
up Abbott Laboratories Healthcare -- 3.41
equal Jubilant Life Sciences Healthcare 12.11 4.15 1.67 3.30
equal Procter & Gamble Health Healthcare 41.02 4.14 0.00 3.20
up Narayana Hrudayalaya Healthcare 47.29 3.07 0.00 2.69
equal Abiomed Inc Healthcare -- 2.67
equal Abbott India Healthcare 56.13 3.47 0.00 2.56
equal Syngene International Healthcare 42.44 3.77 1.97 2.48
equal Dr. Lal Pathlabs Healthcare 59.72 3.14 1.27 2.34
equal ICICI Lombard General Insurance Company Financial 48.83 2.27 1.17 2.07
up Intuitive Surgical Inc. (USA) Healthcare -- 2.04
equal Max India Financial 5.97 4.49 2.02 2.02
down Ajanta Pharma Healthcare 26.33 3.57 2.01 2.01
up Unichem Laboratories Healthcare -- 4.31 1.73 2.01
new Cipla Healthcare 33.31 2.00 0.00 2.00
equal Apollo Hospitals Healthcare 42.20 5.97 1.96 1.96
down Alkem Laboratories Healthcare 24.95 5.53 1.69 1.69

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-May-2020

Fund Manager

— Aditya Khemka since 12-Nov-2018

Education: Mr. Khemka has done B.com, MSc in Finance & MBA

Experience: Prior to joining DSP Mutual Fund, he has worked with Ambit Capital Private Limited, Antique Stock Broking and Nomura Structured Financial Services.

— Vinit Sambre since 12-Nov-2018

Education: Mr. Sambre is a B.Com and FCA.

Experience: Prior to joining DSP he was associated with DSP Merrill Lynch Ltd.(Nov 2005 to Jun 2007), IL & FS Investsmart Ltd. (Dec 2002 to Oct 2005), Unit Trust of India Investment Advisory Services Ltd.(Jun 2000 to Dec 2002), Kisan Ratilal Choksey Shares and Securities Pvt. Ltd. (March 1999 to May 2000) and Credit Rating Information Service of India Ltd.(Apr 1998 to Feb 1999).

Interviews:

Funds Managed:


0.59%

Change from previous, NAV as on 03-Jul-2020

Growth: ₹ 13.7680

Dividend: ₹ 13.7680


Investment Strategy

The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.

Investment Details

Minimum Investment (₹) 500
Minimum Addl Investment (₹) 500
Minimum SIP Investment (₹) 500
Minimum No of Cheques 12
Minimum Withdrawal (₹) 500
Minimum Balance (₹) 500
Exit Load 1% for redemption within 364 days

Basic Details

Fund House: DSP Mutual Fund
Launch Date: 30-Nov-2018
Return Since Launch: 22.25%
Benchmark: S&P BSE Healthcare TRI
Riskometer: High
Type: Open-ended
Assets: ₹ 412 Cr (As on 31-May-2020)
Expense: 2.53% (As on 31-May-2020)
Risk Grade: --
Return Grade: --
Turnover: 14.00%

Contact Information

AMC: DSP Investment Managers Pvt. Ltd.

Address: NATRAJ, Office No. 302-3rd Floor-Plot No. 194, MV Road Junction Western Express Highway, Andheri East Mumbai - 400069

Phone: 022-66178000

Fax: 022-56578181

Website: https://www.dspim.com/

Registrar & Transfer Agent: Computer Age Management Services Ltd.

Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai - 600002

Phone: 1800-3010-6767 / 1800-419-7676

Fax: 044-30407101

Email: [email protected]

Website: www.camsonline.com

Last Session

VR Helpline

Winning and losing

dateSaturday, 04-Jul-2020
time04:00 PM - 05:00 PM

Registration Over